Rhabdomyosarcoma Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Jun 2026A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Children's Oncology Group — PHASE3

TrialNOT YET RECRUITING

Jan 2026A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma

Fudan University — PHASE2

TrialNOT YET RECRUITING

Oct 2025A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma

Eye & ENT Hospital of Fudan University

TrialENROLLING BY INVITATION

Sep 2025FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

National Cancer Institute (NCI) — PHASE1

TrialRECRUITING

May 2025Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma

Xinxin Zhang — EARLY_PHASE1

TrialNOT YET RECRUITING

Mar 2025Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Lille University

TrialRECRUITING

Oct 2024Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Power Life Sciences Inc.

TrialNOT YET RECRUITING

Jun 2024Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen

Sun Yat-sen University — PHASE1, PHASE2

TrialRECRUITING

Mar 2024Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

St. Jude Children's Research Hospital — PHASE2

TrialRECRUITING

Dec 2023Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of First Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study

Sun Yat-sen University — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Rhabdomyosarcoma.
Check the disease page for updates →

Clinical Trial Landscape

15 active trials

1Phase 3

5Phase 2

4Phase 1

2Unknown

3PHASE1, PHASE2

15Total recruiting

Search clinical trials for Rhabdomyosarcoma →

Recent News & Research

No recent news articles indexed yet for Rhabdomyosarcoma.
Search PubMed for Rhabdomyosarcoma →

Browse all Rhabdomyosarcoma news →

Specialist Network

Top 6 by expertise

Ewa Koscielniak, MD

Olgahospital, CWS

Score 361 trial

Andrea Hayes-Jordan, MD

M.D. Anderson Cancer Center

Score 243 trials

Douglas S Hawkins

Children's Oncology Group

📍 Birmingham, Alabama

Score 242 trials17 pubs

Sara M. Federico, MD, MD

St. Jude Children's Research Hospital

📍 MEMPHIS, TN

Score 183 trials

Hongxia Wang, Doctor

Fudan University

Score 162 trials

Alberto S. Pappo, MD, M.D

Texas Children's Cancer Center

📍 MEMPHIS, TN

Score 144 trials1 pub

View all Rhabdomyosarcoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰